Autism

Autism refers to a brain disorder that impairs the ability of a person to communicate.

Autism and Pervasive Developmental Disorders
Kenneth M. Rogers, MD, MSHS
Autism and Pervasive Developmental Disorders.ppt

Autism Spectrum Disorders
Deirdre Moore
Autism Spectrum Disorders.ppt

Autism
Eric Reiss
Autism.ppt

Autism and Related Disorders
Autism and Related Disorders.ppt

Treatments for Autism: An Overview of Model Programs
Fred R Volkmar MD
Treatments for Autism: An Overview of Model Programs.ppt

Autism
DominicaAUTISM.ppt

Autism Spectrum Disorders
By Kirsten Moreland and Kelsey Burns
Autism Spectrum Disorders.ppt

Understanding Students with Autism
Understanding Students with Autism.ppt

Screening and Diagnosis of Autism
P.A. Filipek, MD; P.J. Accardo, MD; S. Ashwal, MD; G.T. Baranek, PhD etal
Screening and Diagnosis of Autism.ppt

Practice Parameter: Medical Treatment of Infantile Spasms
Practice Parameter: Medical Treatment of Infantile Spasms.ppt

Infants at Risk of Autism
Infants at Risk of Autism.ppt

AUTISM & CHILDHOOD DISORDERS
Autism_Medicating Children.ppt

Overview Of Autism
Overview Of Autism.ppt

Childhood Autism Rating Scale (CARS)
Jennifer Connelly
Childhood Autism Rating Scale.ppt

Evaluating Treatments for Children with Autism
Evaluating Treatments for Children with Autism .ppt

Teaching Play to Children with Autism How Do Kids Learn to Play?
Teaching Play to Children with Autism.ppt

Understanding Autism
Sara Porter
Autism.ppt

Evaluating Treatments for Autism
Rachel Hoffman, M. A., Anne Shroyer, B.S
Evaluating Treatments for Autism.ppt

Autism Spectrum Disorder
Autism Spectrum Disorder.ppt

Autism
autism.ppt

WHAT IS Autism Spectrum Disorder?
Dr. Nancy J. Aguinaga
WHAT IS Autism Spectrum Disorder?.ppt

What is the cause of autism?
Sarah Marckstadt
What is the cause of autism?.ppt
600 free full text articles

1. Evaluation of a screening instrument for autism spectrum disorders in prisoners.
2. Understanding autism in schizophrenia.
3. Autism: Recognition, Referral and Diagnosis of Children and Young People on the Autism Spectrum.
4. The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome.
5. Atypical Audiovisual Speech Integration in Infants at Risk for Autism.
6. Imaging-genetics in autism spectrum disorder: advances, translational impact, and future directions.
7. Loci nominally associated with autism from genome-wide analysis show enrichment of brain expression quantitative trait loci but not lymphoblastoid cell line expression quantitative trait loci.
8. [Anti-NMDA-receptor encephalitis: a new axis-III disorder in the differential diagnosis of childhood disintegrative disorder, early onset schizophrenia and late onset autism].
9. Hyperbaric oxygen therapy for treatment of children with autism: a systematic review of randomized trials.
10. Targeting Mitochondria by Olesoxime or Complement 1q Binding Protein as a Novel Management for Autism: A Hypothesis.
11. Abnormal Intracellular Accumulation and Extracellular Aβ Deposition in Idiopathic and Dup15q11.2-q13 Autism Spectrum Disorders.
12. A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism.
13. Reduced functional connectivity within and between 'social' resting state networks in Autism Spectrum Conditions.
14. DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families.
15. High-Throughput Sequencing of mGluR Signaling Pathway Genes Reveals Enrichment of Rare Variants in Autism.
16. Neuroanatomical Assessment of the Integrin β3 Mouse Model Related to Autism and the Serotonin System Using High Resolution MRI.
17. Review of the pharmacotherapy of irritability of autism.
18. A Research Strategy to Discover the Environmental Causes of Autism and Neurodevelopmental Disabilities.
19. The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders.
20. Di(2-ethylhexyl)phthalate and Autism Spectrum Disorders.
21. Effects of a dolphin interaction program on children with autism spectrum disorders - an exploratory research.
22. Maternal Smoking During Pregnancy and the Prevalence of Autism Spectrum Disorders Using Data from the Autism and Developmental Disabilities Monitoring Network.
23. Tipping the Balance of Autism Risk: Potential Mechanisms Linking Pesticides and Autism.
24. The Top 10 Reasons Children With Autism Deserve ABA.
25. Teaching teamwork to adolescents with autism: the cooperative use of activity schedules.
26. The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis.
27. Coloured filters enhance the visual perception of social cues in children with autism spectrum disorders.
28. Above genetics: lessons from cerebral development in autism.
29. The co-morbidity burden of children and young adults with autism spectrum disorders.
30. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism.
31. An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders.
32. Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?
33. A macroepigenetic approach to identify factors responsible for the autism epidemic in the United States.
34. Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders.
35. Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci.
36. Enhanced visual temporal resolution in autism spectrum disorders.
37. Use of prosody and information structure in high functioning adults with autism in relation to language ability.
38. Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages.
39. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.
40. Psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorders.
41. [The putative link between the MMR vaccine and autism and refusal to vaccinate.]
42. Lightening the load: Perceptual load impairs visual detection in typical adults but not in autism.
43. Correlates of age at diagnosis of autism spectrum disorders in six Canadian regions.
44. Status report - National Epidemiologic Database for the Study of Autism in Canada (NEDSAC).
45. Networks of neuronal genes affected by common and rare variants in autism spectrum disorders.
46. Developmental neuroscience of time and number: implications for autism and other neurodevelopmental disabilities.
47. Neural bases of gaze and emotion processing in children with autism spectrum disorders.
48. A systematic review with meta-analysis of comprehensive interventions for preschool children with autism spectrum disorder (ASD): study protocol.
49. Translation and validation of Autism Diagnostic Interview-Revised (ADI-R) for autism diagnosis in Brazil.
50. How sensory experiences of children with and without autism affect family occupations.
51. Evolutionary approaches to autism- an overview and integration.
52. Genomics, intellectual disability, and autism.
53. Infantile zinc deficiency: association with autism spectrum disorders.
54. A comparison of urinary mercury between children with autism spectrum disorders and control children.
55. Harnessing repetitive behaviours to engage attention and learning in a novel therapy for autism: an exploratory analysis.
56. Optimizing the phenotyping of rodent ASD models: enrichment analysis of mouse and human neurobiological phenotypes associated with high-risk autism genes identifies morphological, electrophysiological, neurological, and behavioral features.
57. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.
58. Use of Indian scale for assessment of autism in child guidance clinic: an experience.
59. A microbial association with autism.
60. An fMRI investigation of responses to peer rejection in adolescents with autism spectrum disorders.
61. [Tectal glioma, autism and the use of jokes].
62. [X-chromosome-linked ichthyosis associated to epilepsy, hyperactivity, autism and mental retardation, due to the Xp22.31 microdeletion].
63. Diminished social motivation negatively impacts reputation management: autism spectrum disorders as a case in point.
64. Neural systems for speech and song in autism.
65. Genetics and mitochondrial abnormalities in autism spectrum disorders: a review.
66. Infant neural sensitivity to dynamic eye gaze is associated with later emerging autism.
67. Profiles of receptive and expressive language abilities in boys with comorbid fragile X syndrome and autism.
68. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances.
69. Parent-reported health care expenditures associated with autism spectrum disorders in Heilongjiang province, China.
70. Excess of non-verbal cases of autism spectrum disorders presenting to orthodox clinical practice in Africa - a trend possibly resulting from late diagnosis and intervention.
71. Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study.
72. Randomised controlled trial of improvisational music therapy's effectiveness for children with autism spectrum disorders (TIME-A): study protocol.
73. Direct and distal effects of noncontingent juice on rumination exhibited by a child with autism.
74. Using conditional discrimination training to produce emergent relations between coins and their values in children with autism.
75. Establishing verbal repertoires in children with autism using function-based video modeling.
76. Autism spectrum disorder and celiac disease: no evidence for a link.
77. Discriminant and concurrent validity of a simplified DSM-based structured diagnostic instrument for the assessment of autism spectrum disorders in youth and young adults.
78. Acupuncture for treatment of autism spectrum disorders.
79. Evaluation of semantic-based information retrieval methods in the autism phenotype domain.
80. Organic mental disorder after pneumococcal meningoencephalitis with autism-like symptoms.
81. The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.
82. Early childhood predictors of the social competence of adults with autism.
83. RECENT DEVELOPMENTS IN NEUROPATHOLOGY OF AUTISM SPECTRUM DISORDERS.
84. A brain region-specific predictive gene map for autism derived by profiling a reference gene set.
85. Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism.
86. The plausibility of a role for mercury in the etiology of autism: a cellular perspective.
87. Effect of a vitamin/mineral supplement on children and adults with autism.
88. Oral manifestations in a group of adults with autism spectrum disorder.
89. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.
90. AutismKB: an evidence-based knowledgebase of autism genetics.
91. Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study.
92. Neuro-inflammation, blood-brain barrier, seizures and autism.
93. A systems biological study on the comorbidity of autism spectrum disorders and bipolar disorder.
94. Brain enlargement is associated with regression in preschool-age boys with autism spectrum disorders.
95. The potential role of probiotics in the management of childhood autism spectrum disorders.
96. Autism and exergaming: effects on repetitive behaviors and cognition.
97. Mutations causing syndromic autism define an axis of synaptic pathophysiology.
98. Replication of the association of a MET variant with autism in a Chinese Han population.
99. Participation in social activities among adolescents with an autism spectrum disorder.
100. A survey of Autism knowledge and attitudes among the healthcare professionals in Lahore, Pakistan.
101. Early manifestations of autism spectrum disorders. Experience of 393 cases in a child neurological centre.
102. Autism spectrum traits predict the neural response to eye gaze in typical individuals.
103. Characteristics of autism spectrum disorders in a sample of egyptian and saudi patients: transcultural cross sectional study.
104. An X chromosome-wide association study in autism families identifies TBL1X as a novel autism spectrum disorder candidate gene in males.
105. Quantifying and modeling birth order effects in autism.
106. Measurement of autism: a review of four screening measures.
107. Autism risk assessment in siblings of affected children using sex-specific genetic scores.
108. mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism.
109. Copy number variants in extended autism spectrum disorder families reveal candidates potentially involved in autism risk.
110. Investigation of the serum levels of anterior pituitary hormones in male children with autism.
111. The physical activity patterns of children with autism.
112. Facial phenotypes in subgroups of prepubertal boys with autism spectrum disorders are correlated with clinical phenotypes.
113. Alteration of plasma glutamate and glutamine levels in children with high-functioning autism.
114. Autism spectrum disorders and schizophrenia: meta-analysis of the neural correlates of social cognition.
115. A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder.
116. Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology.
117. Insensitivity to social reputation in autism.
118. Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders.
119. [The symptoms of autism spectrum disorders in the first two years of life: a review of longitudinal prospective studies].
120. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.
121. An integrated meta-analysis of two variants in HOXA1/HOXB1 and their effect on the risk of autism spectrum disorders.
122. Auditory-motor mapping training as an intervention to facilitate speech output in non-verbal children with autism: a proof of concept study.
123. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice.
124. Epilepsy in autism: features and correlates.
125. Facial emotion recognition deficits in relatives of children with autism are not associated with 5HTTLPR.
126. Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism.
127. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances.
128. Association of hypomelanotic skin disorders with autism: links to possible etiologic role of vitamin-D levels in autism?
129. Comparing social attention in autism and amygdala lesions: effects of stimulus and task condition.
130. [An approach to the executive functions in autism spectrum disorder].
131. [Autism spectrum disorders and mu rhythm. A new neurophysiological view].
132. The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy.
133. A comparison of prompting tactics to establish intraverbals in children with autism.
134. Effects of music on vocal stereotypy in children with autism.
135. A comparison of methods for teaching receptive labeling to children with autism spectrum disorders.
136. IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase δ.
137. Therapies for Children With Autism Spectrum Disorders: A Review of the Research for Parents and Caregivers.
138. Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders.
139. Genetics of autism spectrum disorders.
140. Autism-associated gene expression in peripheral leucocytes commonly observed between subjects with autism and healthy women having autistic children.
141. Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways.
142. A systems approach towards an understanding, diagnosis and personalized treatment of autism spectrum disorders.
143. [Perceptual characteristics of peripheral vision in children with autism].
144. Brain region-specific decrease in the activity and expression of protein kinase A in the frontal cortex of regressive autism.
145. Association of transcription factor gene LMX1B with autism.
146. Autism spectrum disorders.
147. Autism spectrum disorders.
148. What can we learn about autism from studying fragile X syndrome?
149. Low plasma progranulin levels in children with autism.
150. Autism and metabolic cytopathy.
151. Multisensory integration and attention in autism spectrum disorder: evidence from event-related potentials.
152. Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders.
153. Repetitive behavior profiles: Consistency across autism spectrum disorder cohorts and divergence from Prader-Willi syndrome.
154. CD38 gene knockout juvenile mice: a model of oxytocin signal defects in autism.
155. MMR vaccine and autism: vaccine nihilism and postmodern science.
156. Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders.
157. Aging in autism spectrum disorders: a mini-review.
158. Autism spectrum disorders (ASD) in Africa: a perspective.
159. Decreased expression of axon-guidance receptors in the anterior cingulate cortex in autism.
160. Prader-Willi syndrome and autism spectrum disorders: an evolving story.
161. Memory functioning in children and adolescents with autism.
162. Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders.
163. Social Responsiveness Scale-aided analysis of the clinical impact of copy number variations in autism.
164. Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk.
165. Therapies for Children With Autism Spectrum Disorders.
166. Autism: a "critical period" disorder?
167. Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study.
168. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function.
169. Links between genetics and pathophysiology in the autism spectrum disorders.
170. Commentary: Low-Dose Risperidone-Induced Oculogyric Crises in an Adolescent Male with Autism, Tourette's and Developmental Delay.
171. Low-Dose Risperidone-Induced Oculogyric Crises in an Adolescent Male with Autism, Tourette's and Developmental Delay.
172. Ancestry of pink disease (infantile acrodynia) identified as a risk factor for autism spectrum disorders.
173. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism.
174. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.
175. The MMR vaccine and autism: Sensation, refutation, retraction, and fraud.
176. Alterations of GABAergic signaling in autism spectrum disorders.
177. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?
178. Regional cerebral blood flow in children with autism spectrum disorders: a quantitative ⁹⁹mTc-ECD brain SPECT study with statistical parametric mapping evaluation.
179. New perspectives on rodent models of advanced paternal age: relevance to autism.
180. Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker.
181. Transient and steady-state auditory gamma-band responses in first-degree relatives of people with autism spectrum disorder.
182. Symbolic play of preschoolers with severe communication impairments with autism and other developmental delays: more similarities than differences.
183. Effects of picture exchange communication system on communication and behavioral anomalies in autism.
184. A strategy to identify de novo mutations in common disorders such as autism and schizophrenia.
185. Genetics in autism diagnosis: adding molecular subtypes to neurobehavioral diagnoses.
186. Establishing compliance with liquid medication administration in a child with autism.
187. Further analysis of picture interference when teaching word recognition to children with autism.
188. Using multiple-exemplar training to teach a generalized repertoire of sharing to children with autism.
189. A behavioral comparison of male and female adults with high functioning autism spectrum conditions.
190. Why are autism spectrum conditions more prevalent in males?
191. Managing anxiety and depressive symptoms in adults with autism-spectrum disorders.
192. The interplay between attentional strategies and language processing in high-functioning adults with autism spectrum disorder.
193. Brief report: the dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD).
194. Preliminary Investigation of the Sources of Self-Efficacy Among Teachers of Students with Autism.
195. The Effects of Consultation on Individualized Education Program Outcomes for Young Children With Autism: The Collaborative Model for Promoting Competence and Success.
196. MRI study of minor physical anomaly in childhood autism implicates aberrant neurodevelopment in infancy.
197. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
198. A close eye on the eagle-eyed visual acuity hypothesis of autism.
199. Elderly with autism: executive functions and memory.
200. In-Home Training for Fathers of Children with Autism: A Follow up Study and Evaluation of Four Individual Training Components.
201. Protein interactome reveals converging molecular pathways among autism disorders.
202. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity.
203. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.
204. Administrative censoring in ecological analyses of autism and a Bayesian solution.
205. Risk as Social Context: Immigration Policy and Autism in California.
206. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus.
207. Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation.
208. Dental caries experience, oral health status and treatment needs of dental patients with autism.
209. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders.
210. FMR1 premutation and full mutation molecular mechanisms related to autism.
211. Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder.
212. A quantitative association study of SLC25A12 and restricted repetitive behavior traits in autism spectrum disorders.
213. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism.
214. Infant EEG activity as a biomarker for autism: a promising approach or a false promise?
215. Response: Infant EEG activity as a biomarker for autism: a promising approach or a false promise?
216. Autism and the Environment: Challenges and Opportunities for Research: Workshop Proceedings.
217. [Profile of children and adolescents with autism spectrum disorders in an institution in Bogota, Colombia].
218. Congenital rubella syndrome and autism spectrum disorder prevented by rubella vaccination--United States, 2001-2010.
219. Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey.
220. [Facial emotion recognition deficits in relatives of children with autism are not associated with 5HTTLPR.]
221. Dejian mind-body intervention improves the cognitive functions of a child with autism.
222. Early diagnoses of autism spectrum disorders in Massachusetts birth cohorts, 2001-2005.
223. In search of cellular immunophenotypes in the blood of children with autism.
224. A study of nuclear transcription factor-kappa B in childhood autism.
225. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.
226. Evidence for association between Disrupted-in-Schizophrenia 1 (DISC1) gene polymorphisms and autism in Chinese Han population: a family-based association study.
227. A sex-specific association of common variants of neuroligin genes (NLGN3 and NLGN4X) with autism spectrum disorders in a Chinese Han cohort.
228. Access to specialty care in autism spectrum disorders-a pilot study of referral source.
229. AUTISM Spectrum Disorders and Suicidality.
230. Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism.
231. Increased sensitivity to mirror symmetry in autism.
232. Novel autism subtype-dependent genetic variants are revealed by quantitative trait and subphenotype association analyses of published GWAS data.
233. Dysregulation of fragile × mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: a postmortem brain study.
234. Socioeconomic Status and the Increased Prevalence of Autism in California.
235. ANS: aberrant neurodevelopment of the social cognition network in adolescents with autism spectrum disorders.
236. Response interruption and redirection for vocal stereotypy in children with autism: a systematic replication.
237. Assessment and treatment of foot-shoe fetish displayed by a man with autism.
238. Increasing compliance with medical examination requests directed to children with autism: effects of a high-probability request procedure.
239. Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years.
240. All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from Autism spectrum disorder.
241. Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism.
242. Pervasive developmental disorders and autism spectrum disorders: are these disorders one and the same?
243. Genome-wide association scan of korean autism spectrum disorders with language delay: a preliminary study.
244. Sleep in children with autism with and without autistic regression.
245. Narrative Skill in Boys with Fragile X Syndrome with and without Autism Spectrum Disorder.
246. A new synaptic player leading to autism risk: Met receptor tyrosine kinase.
247. Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here.
248. Autism and the amygdala: commentary on Hewitson and coauthors (2010).
249. Lipidomics: the function of vital lipids in embryogenesis preventing autism spectrum disorders, treating sterile inflammatory diatheses with a lymphopoietic central nervous system component.
250. Circuit-specific intracortical hyperconnectivity in mice with deletion of the autism-associated Met receptor tyrosine kinase.
251. Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder.
252. Novel method for combined linkage and genome-wide association analysis finds evidence of distinct genetic architecture for two subtypes of autism.
253. A family with autism and rare copy number variants disrupting the Duchenne/Becker muscular dystrophy gene DMD and TRPM3.
254. Glutathione pathway gene variation and risk of autism spectrum disorders.
255. The benefit of directly comparing autism and schizophrenia for revealing mechanisms of social cognitive impairment.
256. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.
257. The each child study: systematic screening for autism spectrum disorders in a pediatric setting.
258. D-cycloserine facilitates socially reinforced learning in an animal model relevant to autism spectrum disorders.
259. Basal ganglia morphometry and repetitive behavior in young children with autism spectrum disorder.
260. Autism and intellectual disability are differentially related to sociodemographic background at birth.
261. Autism biomarkers for more efficacious diagnosis.
262. Outcomes of behavioral intervention for children with autism in mainstream pre-school settings.
263. Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption.
264. Reassessing the role of mitochondrial DNA mutations in autism spectrum disorder.
265. Are children with autism good or bad learners?
266. A systematic review of secretin for children with autism spectrum disorders.
267. A systematic review of medical treatments for children with autism spectrum disorders.
268. A systematic review of early intensive intervention for autism spectrum disorders.
269. Functionality of promoter microsatellites of arginine vasopressin receptor 1A (AVPR1A): implications for autism.
270. Prenatal exposure of a girl with autism spectrum disorder to 'horsetail' (Equisetum arvense) herbal remedy and alcohol: a case report.
271. Reduced transcript expression of genes affected by inherited and de novo CNVs in autism.
272. Autism symptoms and internalizing psychopathology in girls and boys with autism spectrum disorders.
273. Neural correlates of familiar and unfamiliar face processing in infants at risk for autism spectrum disorders.
274. [Psychometric attributes of the Spanish version of A-TAC screening scale for autism spectrum disorders].
275. [Treatment of behavioral disorders by risperidone in children with autism].
276. Credible knowledge: a pilot evaluation of a modified GRADE method using parent-implemented interventions for children with autism.
277. Enhanced cortisol response to stress in children in autism.
278. Synaptic signaling and aberrant RNA splicing in autism spectrum disorders.
279. Risk and correlates of autism spectrum disorder in children with epilepsy: a community-based study.
280. Social communication deficits in the general population: how far out does the autism spectrum go?
281. Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism.
282. Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity.
283. Can Asperger syndrome be distinguished from autism? An anatomic likelihood meta-analysis of MRI studies.
284. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex.
285. Expressive morphosyntax in boys with Fragile X syndrome with and without autism spectrum disorder.
286. Variations of the candidate SEZ6L2 gene on Chromosome 16p11.2 in patients with autism spectrum disorders and in human populations.
287. Prevalence of autism spectrum conditions in a youth mental health service.
288. The changing prevalence of the autism spectrum disorders.
289. Autism in Brazil: perspectives from science and society.
290. Inter-regional brain communication and its disturbance in autism.
291. Gain-of-function glutamate receptor interacting protein 1 variants alter GluA2 recycling and surface distribution in patients with autism.
292. Daytime sleep patterns in preschool children with autism, developmental delay, and typical development.
293. Autism and increased paternal age related changes in global levels of gene expression regulation.
294. Autism spectrum disorder is related to endoplasmic reticulum stress induced by mutations in the synaptic cell adhesion molecule, CADM1.
295. Jaundice-autism link unconvincing.
296. Quantitative analysis of the shape of the corpus callosum in patients with autism and comparison individuals.
297. Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism.
298. A de novo 1.5 Mb microdeletion on chromosome 14q23.2-23.3 in a patient with autism and spherocytosis.
299. Brief report: symptom onset patterns and functional outcomes in young children with autism spectrum disorders.
300. Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism.
301. Characteristics of late-onset epilepsy and EEG findings in children with autism spectrum disorders.
302. Genomic and epigenomic instability, fragile sites, schizophrenia and autism.
303. Establishing five derived mands in three adolescent boys with autism.
304. Teaching effective hand raising to children with autism during group instruction.
305. Rare structural variation of synapse and neurotransmission genes in autism.
306. Intentional Minds: A Philosophical Analysis of Intention Tested through fMRI Experiments Involving People with Schizophrenia, People with Autism, and Healthy Individuals.
307. MMR vaccination and autism: learnings and implications.
308. EEG complexity as a biomarker for autism spectrum disorder risk.
309. [Life transition of mothers of children with autism].
310. Atypical neural networks for social orienting in autism spectrum disorders.
311. Virtual conversation partner for adults with autism.
312. The Swedish version of the Ritvo autism and asperger diagnostic scale: revised (RAADS-R). A validation study of a rating scale for adults.
313. Overlap of autism and seizures: understanding cognitive comorbidity.
314. Evidence to practice: treatment of anxiety in individuals with autism spectrum disorders.
315. Change in maternal criticism and behavior problems in adolescents and adults with autism across a 7-year period.
316. Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures.
317. Contactin 4 as an autism susceptibility locus.
318. Phonology and vocal behavior in toddlers with autism spectrum disorders.
319. Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders.
320. Post-high school service use among young adults with an autism spectrum disorder.
321. The neurology of autism spectrum disorders.
322. Marital satisfaction and parenting experiences of mothers and fathers of adolescents and adults with autism.
323. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?
324. Structural MRI in autism spectrum disorder.
325. Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.
326. Sensory processing in autism: a review of neurophysiologic findings.
327. Characterization of the deleted in autism 1 protein family: implications for studying cognitive disorders.
328. Impaired theory of mind for moral judgment in high-functioning autism.
329. Arousal and activity choice in autism: A single case assessment integrating autonomic and behavioral analysis.
330. Animal model integration to AutDB, a genetic database for autism.
331. Reduced central white matter volume in autism: implications for long-range connectivity.
332. DIA1R is an X-linked gene related to Deleted In Autism-1.
333. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.
334. Altered auditory and multisensory temporal processing in autism spectrum disorders.
335. Deficits in adults with autism spectrum disorders when processing multiple objects in dynamic scenes.
336. A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism.
337. Time trends in autism.
338. Research review: Constraining heterogeneity: the social brain and its development in autism spectrum disorder.
339. General anaesthesia for insertion of an automated implantable cardioverter defibrillator in a child with Brugada and autism.
340. Closely spaced pregnancies are associated with increased odds of autism in California sibling births.
341. Assessment of knowledge about childhood autism among paediatric and psychiatric nurses in Ebonyi state, Nigeria.
342. Autism spectrum disorders and fetal hypoxia in a population-based cohort: accounting for missing exposures via Estimation-Maximization algorithm.
343. The self in autism: an emerging view from neuroimaging.
344. Polybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study.
345. Evaluation of Pax6 mutant rat as a model for autism.
346. Neural pathways for language in autism: the potential for music-based treatments.
347. Aberrant striatal functional connectivity in children with autism.
348. Randomized controlled trial of electro-acupuncture for autism spectrum disorder.
349. Analysis of Parent, Teacher, and Consultant Speech Exchanges and Educational Outcomes of Students With Autism During COMPASS Consultation.
350. Teaching a child with autism to mand for information using "how".
351. Rule-governed behavior: teaching a preliminary repertoire of rule-following to children with autism.
352. Effects of conditioning voices as reinforcers for listener responses on rate of learning, awareness, and preferences for listening to stories in preschoolers with autism.
353. Acquisition of mands, tacts, and intraverbals through sign exposure in an individual with autism.
354. Further evaluation of prompting tactics for establishing intraverbal responding in children with autism.
355. Intraverbal behavior and verbal conditional discriminations in typically developing children and children with autism.
356. The intense world theory - a unifying theory of the neurobiology of autism.
357. Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene.
358. In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism.
359. Atypical diffusion tensor hemispheric asymmetry in autism.
360. Children with autism are neither systematic nor optimal foragers.
361. [Mental health state of parents of children with autism.]
362. Trajectories of emotional well-being in mothers of adolescents and adults with autism.
363. Atypical categorization in children with high-functioning autism spectrum disorder.
364. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication.
365. Can magnetic resonance imaging aid diagnosis of the autism spectrum?
366. Residential proximity to freeways and autism in the CHARGE study.
367. Diagnosing autism spectrum disorders in adults: the use of Autism Diagnostic Observation Schedule (ADOS) module 4.
368. Brazilian scientific output on autism spectrum disorders.
369. Children with high functioning autism show increased prefrontal and temporal cortex activity during error monitoring.
370. Prevalence of behavioural and emotional problems in children with high-functioning autism spectrum disorders.
371. Autoantibodies to cerebellum in children with autism associate with behavior.
372. The promise and the pitfalls of autism research: an introductory note for new autism researchers.
373. Limited activity monitoring in toddlers with autism spectrum disorder.
374. Diffusion tensor imaging in autism spectrum disorders: preliminary evidence of abnormal neural connectivity.
375. Conserved subcortical and divergent cortical expression of proteins encoded by orthologs of the autism risk gene MET.
376. Intervention targeting development of socially synchronous engagement in toddlers with autism spectrum disorder: a randomized controlled trial.
377. Combined linkage and linkage disequilibrium analysis of a motor speech phenotype within families ascertained for autism risk loci.
378. Dental education and dentists' attitudes and behavior concerning patients with autism.
379. Increasing response diversity in children with autism.
380. Comparison of simultaneous prompting and no-no prompting in two-choice discrimination learning with children with autism.
381. Evaluation of resistance to change under different disrupter conditions in children with autism and severe intellectual disability.
382. Low-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Modulates Evoked-Gamma Frequency Oscillations in Autism Spectrum Disorder (ASD).
383. Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.
384. Examining autistic traits in children with ADHD: does the autism spectrum extend to ADHD?
385. Anterior EEG asymmetry and the Modifier Model of Autism.
386. Family-based association study of ITGB3 in autism spectrum disorder and its endophenotypes.
387. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.
388. White matter compromise of callosal and subcortical fiber tracts in children with autism spectrum disorder: a diffusion tensor imaging study.
389. Multiple autism-like behaviors in a novel transgenic mouse model.
390. Virtual reality in pediatric neurorehabilitation: attention deficit hyperactivity disorder, autism and cerebral palsy.
391. The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R): a scale to assist the diagnosis of Autism Spectrum Disorder in adults: an international validation study.
392. Perceptual reasoning predicts handwriting impairments in adolescents with autism.
393. Neural signatures of autism.
394. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.
395. New insights regarding possible association between prenatal ultrasound and autism.
396. [Assessment of comorbidity in autism spectrum disorders].
397. Evaluation of the validity of the Autism Spectrum Quotient (AQ) in differentiating high-functioning autistic spectrum disorder from schizophrenia.
398. Autism: from research to practice.
399. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia.
400. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2.
401. Behavioral and cerebellar transmission deficits in mice lacking the autism-linked gene islet brain-2.
402. Changes in prefrontal axons may disrupt the network in autism.
403. Using a self-organizing map algorithm to detect age-related changes in functional connectivity during rest in autism spectrum disorders.
404. Rapid eye movement sleep percentage in children with autism compared with children with developmental delay and typical development.
405. Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism.
406. Neural activation to emotional faces in adolescents with autism spectrum disorders.
407. Sibling Adjustment and Maternal Well-Being: An Examination of Families With and Without a Child With an Autism Spectrum Disorder.
408. Autism spectrum features in Smith-Magenis syndrome.
409. Psychotherapy treatment program in a group of adults with high-functioning autism spectrum disorder.
410. Theory of Mind training in children with autism: a randomized controlled trial.
411. Unaffected perceptual thresholds for biological and non-biological form-from-motion perception in autism spectrum conditions.
412. Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders.
413. Age of diagnosis for autism: individual and community factors across 10 birth cohorts.
414. Trends in the prevalence of autism on the basis of special education data.
415. The actual prevalence of autism: are we there yet?
416. Obsessions and compulsions in children with Asperger's syndrome or high-functioning autism: a case-control study.
417. The hypothesis of apraxia of speech in children with autism spectrum disorder.
418. Rare familial 16q21 microdeletions under a linkage peak implicate cadherin 8 (CDH8) in susceptibility to autism and learning disability.
419. Health care expenditures for children with autism spectrum disorders in Medicaid.
420. Pervasive microstructural abnormalities in autism: a DTI study.
421. Genetic testing for autism: recent advances and clinical implications.
422. Genome-scan for IQ discrepancy in autism: evidence for loci on chromosomes 10 and 16.
423. Using global unique identifiers to link autism collections.
424. The genetics of child psychiatric disorders: focus on autism and Tourette syndrome.
425. Changing the landscape of autism research: the autism genetic resource exchange.
426. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome.
427. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment.
428. Biological changes in auditory function following training in children with autism spectrum disorders.
429. Application of integrated yoga therapy to increase imitation skills in children with autism spectrum disorder.
430. Autism spectrum disorders, maternal characteristics and obstetric complications among singletons born in Alberta, Canada.
431. PCR and serology find no association between xenotropic murine leukemia virus-related virus (XMRV) and autism.
432. Dysfunctions in brain networks supporting empathy: an fMRI study in adults with autism spectrum disorders.
433. The autism-vaccine story: fiction and deception?
434. Decreased interhemispheric functional connectivity in autism.
435. Neonatal jaundice, autism, and other disorders of psychological development.
436. Contrast sensitivity for motion detection and direction discrimination in adolescents with autism spectrum disorders and their siblings.
437. Health-related quality of life in adolescents and young adults with high functioning autism-spectrum disorder.
438. Social peers rescue autism-relevant sociability deficits in adolescent mice.
439. Self-referenced processing, neurodevelopment and joint attention in autism.
440. Age-related temporal and parietal cortical thinning in autism spectrum disorders.
441. Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.
442. Narrowing the broader autism phenotype: a study using the Communication Checklist-Adult Version (CC-A).
443. Targeting neurotensin as a potential novel approach for the treatment of autism.
444. Sibling recurrence and the genetic epidemiology of autism.
445. Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism.
446. VEP contrast sensitivity responses reveal reduced functional segregation of mid and high filters of visual channels in autism.
447. Three important things to consider when starting intervention for a child diagnosed with autism.
448. Three important things to consider when starting intervention for a child diagnosed with autism.
449. Three important things to consider when starting intervention for a child diagnosed with autism.
450. Three important things to consider when starting intervention for a child diagnosed with autism.
451. Designing and evaluating assessment-based interventions to reduce stereotypy among adults with autism in a community job.
452. On the Use of Fluency Training in the Behavioral Treatment of Autism: A Commentary.
453. Facial identity recognition in the broader autism phenotype.
454. Elevated cortisol during play is associated with age and social engagement in children with autism.
455. Early functional brain development in autism and the promise of sleep fMRI.
456. Bridging the gap between MRI and postmortem research in autism.
457. Local information processing in adults with high functioning autism and asperger syndrome: the usefulness of neuropsychological tests and self-reports.
458. Mothers' reports of play dates and observation of school playground behavior of children having high-functioning autism spectrum disorders.
459. Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism.
460. A de novo marker chromosome derived from 9p in a patient with 9p partial duplication syndrome and autism features: genotype-phenotype correlation.
461. Population-based study of genetic variation in individuals with autism spectrum disorders from Croatia.
462. Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.
463. Vitamin B12 optic neuropathy in autism.
464. Pragmatic language and school related linguistic abilities in siblings of children with autism.
465. Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability.
466. Atypical reflexive gaze patterns on emotional faces in autism spectrum disorders.
467. Autism and childhood vaccinations: debunking the myth.
468. Autism and X-linked hypophosphatemia: A possible association?
469. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
470. Enlarged right superior temporal gyrus in children and adolescents with autism.
471. Kiddie-SADS reveals high rates of DSM-IV disorders in children and adolescents with autism spectrum disorders.
472. Parent-of-origin effects in autism identified through genome-wide linkage analysis of 16,000 SNPs.
473. Lack of developmental improvement on a face memory task during adolescence in autism.
474. [Abnormal intestinal permeability in children with autism].
475. Intensive intervention for children and adolescents with autism in a community setting in Italy: a single-group longitudinal study.
476. [Autism and pain - a literature review].
477. Recent studies on feeding problems in children with autism.
478. Using complex auditory-visual samples to produce emergent relations in children with autism.
479. Teaching abduction-prevention skills to children with autism.
480. Acquisition of intraverbal behavior: teaching children with autism to mand for answers to questions.
481. Randomized controlled trial of electro-acupuncture for autism spectrum disorder.
482. The origins of social impairments in autism spectrum disorder: studies of infants at risk.
483. Parental autoimmune diseases associated with autism spectrum disorders in offspring.
484. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts.
485. Cortical underconnectivity coupled with preserved visuospatial cognition in autism: Evidence from an fMRI study of an embedded figures task.
486. Autism in fragile X syndrome: a category mistake?
487. Autism spectrum disorders, schizophrenia and diagnostic confusion.
488. The relative risk and timing of divorce in families of children with an autism spectrum disorder.
489. Altering the trajectory of early postnatal cortical development can lead to structural and behavioural features of autism.
490. Rapid automatized naming as an index of genetic liability to autism.
491. A mutant form of PTEN linked to autism.
492. Perception of emotion in musical performance in adolescents with autism spectrum disorders.
493. Bridging the research-to-practice gap in autism intervention: an application of diffusion of innovation theory.
494. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.
495. Describing the brain in autism in five dimensions--magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach.
496. Invertebrate insights into autism.
497. Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3.
498. The construction and validation of an abridged version of the autism-spectrum quotient (AQ-Short).
499. Autism and Anthropology?
500. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder.
501. Neurobehavioral abnormalities in first-degree relatives of individuals with autism.
502. Defining the broader, medium and narrow autism phenotype among parents using the Autism Spectrum Quotient (AQ).
503. Candidate gene study of HOXB1 in autism spectrum disorder.
504. Genome-wide linkage using the Social Responsiveness Scale in Utah autism pedigrees.
505. Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry.
506. A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critical region.
507. Genome-wide linkage analyses of two repetitive behavior phenotypes in Utah pedigrees with autism spectrum disorders.
508. Paternal age increases the risk for autism in an Iranian population sample.
509. Molecular Autism: accelerating and integrating research into neurodevelopmental conditions.
510. Assessing the impact of a combined analysis of four common low-risk genetic variants on autism risk.
511. Age of diagnosis among Medicaid-enrolled children with autism, 2001-2004.
512. Social involvement of children with autism spectrum disorders in elementary school classrooms.
513. Immunization Safety Review: Vaccines and Autism.
514. Common circuit defect of excitatory-inhibitory balance in mouse models of autism.
515. A genome-wide scan for common alleles affecting risk for autism.
516. Learning in autism: implicitly superb.
517. The Impact of Health Problems on Behavior Problems in Adolescents and Adults With Autism Spectrum Disorders: Implications for Maternal Burden.
518. Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.
519. Autism, language and communication in children with sex chromosome trisomies.
520. "Hunting with a knife and ... fork": examining central coherence in autism, attention deficit/hyperactivity disorder, and typical development with a linguistic task.
521. Infant head growth in male siblings of children with and without autism spectrum disorders.
522. Severe Progressive Autism Associated with Two de novo Changes: A 2.6-Mb 2q31.1 Deletion and a Balanced t(14;21)(q21.1;p11.2) Translocation with Long-Range Epigenetic Silencing of LRFN5 Expression.
523. The integration of prosodic speech in high functioning autism: a preliminary FMRI study.
524. Automated vocal analysis of naturalistic recordings from children with autism, language delay, and typical development.
525. Feeding symptoms, dietary patterns, and growth in young children with autism spectrum disorders.
526. Aripiprazole in autism spectrum disorders and fragile X syndrome.
527. Tetrahydrobiopterin as a novel therapeutic intervention for autism.
528. Overlaps between autism and language impairment: phenomimicry or shared etiology?
529. Brief report: theatre as therapy for children with autism spectrum disorder.
530. Employment and post-secondary educational activities for young adults with autism spectrum disorders during the transition to adulthood.
531. Latina Mothers Caring for a Son or Daughter with Autism or Schizophrenia: Similarities, Differences and the Relationship Between Co-Residency and Maternal Well-Being.
532. Intact imitation of emotional facial actions in autism spectrum conditions.
533. Socioeconomic inequality in the prevalence of autism spectrum disorder: evidence from a U.S. cross-sectional study.
534. Association between a high-risk autism locus on 5p14 and social communication spectrum phenotypes in the general population.
535. Location, Location, Location: Alterations in the Functional Topography of Face- but not Object- or Place-Related Cortex in Adolescents with Autism.
536. Behavioral and physiological responses to child-directed speech as predictors of communication outcomes in children with autism spectrum disorders.
537. Can autism be triggered by acetaminophen activation of the endocannabinoid system?
538. The biological basis of autism spectrum disorders: Understanding causation and treatment by clinical geneticists.
539. Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature.
540. Blood mercury levels in autism spectrum disorder: Is there a threshold level?
541. Sorting out the spinning of autism: heavy metals and the question of incidence.
542. The review of most frequently occurring medical disorders related to aetiology of autism and the methods of treatment.
543. Locomotor activity, object exploration and space preference in children with autism and Down syndrome.
544. Lifetime care for patients with autism.
545. Autism from a biometric perspective.
546. Autism spectrum disorders.
547. Abnormal functional connectivity of default mode sub-networks in autism spectrum disorder patients.
548. Detecting corpus callosum abnormalities in autism based on anatomical landmarks.
549. [Autism: overestimation of the genetic origins].
550. Standardized ADOS scores: measuring severity of autism spectrum disorders in a Dutch sample.
551. Identifying loci for the overlap between attention-deficit/hyperactivity disorder and autism spectrum disorder using a genome-wide QTL linkage approach.
552. Social demographic change and autism.
553. Parent-child DRD4 genotype as a potential biomarker for oppositional, anxiety, and repetitive behaviors in children with autism spectrum disorder.
554. Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism.
555. Restricted and repetitive behaviors in toddlers and preschoolers with autism spectrum disorders based on the Autism Diagnostic Observation Schedule (ADOS).
556. Thimerosal-containing vaccines and autism: a review of recent epidemiologic studies.
557. Exposure to environmental toxins in mothers of children with autism spectrum disorder.
558. Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism.
559. The Autism Birth Cohort: a paradigm for gene-environment-timing research.
560. Behavioral profiles of affected and unaffected siblings of children with autism: contribution of measures of mother-infant interaction and nonverbal communication.
561. Autism spectrum disorder in children and adolescents with fragile X syndrome: within-syndrome differences and age-related changes.
562. Comparisons between individuals with autism spectrum disorders and individuals with Down syndrome in adulthood.
563. Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8.
564. Behavioural phenotyping assays for mouse models of autism.
565. Atypical network connectivity for imitation in autism spectrum disorder.
566. Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism.
567. Court finds no Vaccines-autism link.
568. Response to distress in infants at risk for autism: a prospective longitudinal study.
569. Can family affectedness inform infant sibling outcomes of autism spectrum disorders?
570. White matter integrity and pictorial reasoning in high-functioning children with autism.
571. Factors influencing knowledge about childhood autism among final year undergraduate Medical, Nursing and Psychology students of University of Nigeria, Enugu State, Nigeria.
572. Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism.
573. Functional impact of global rare copy number variation in autism spectrum disorders.
574. Nova Scotia contemplates a continuum of coordinated, lifetime care for autism patients.
575. Dissecting the clinical heterogeneity of autism spectrum disorders through defined genotypes.
576. Impaired Error Monitoring and Correction Function in Autism.
577. Brief report: Sensorimotor gating in idiopathic autism and autism associated with fragile X syndrome.
578. Amygdala engagement in response to subthreshold presentations of anxious face stimuli in adults with autism spectrum disorders: preliminary insights.
579. Revisiting Bleuler: relationship between autism and schizophrenia.
580. Magnocellular visual evoked potential delay with high autism spectrum quotient yields a neural mechanism for altered perception.
581. Early-stage visual processing abnormalities in high-functioning autism spectrum disorder (ASD).
582. Effects of cognitive behavioral therapy on daily living skills in children with high-functioning autism and concurrent anxiety disorders.
583. Social influence and the autism epidemic.
584. Effect of propranolol on functional connectivity in autism spectrum disorder--a pilot study.
585. Patterns of visual attention to faces and objects in autism spectrum disorder.
586. Autism in 1959: Joey the mechanical boy.
587. Plasma 25(OH)D concentration in children with autism spectrum disorder.
588. Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial.
589. How does the topic of conversation affect verbal exchange and eye gaze? A comparison between typical development and high-functioning autism.
590. On the aetiology of autism.
591. Perception of shadows in children with autism spectrum disorders.
592. Atypical gaze patterns in children and adults with autism spectrum disorders dissociated from developmental changes in gaze behaviour.
593. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.
594. A novel frameshift mutation in UPF3B identified in brothers affected with childhood onset schizophrenia and autism spectrum disorders.
595. Morphological features in children with autism spectrum disorders: a matched case-control study.
596. Evolving role of MeCP2 in Rett syndrome and autism.
597. Normal movement selectivity in autism.
598. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.
599. A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism.
600. Abstract reasoning and friendship in high functioning preadolescents with autism spectrum disorders.